Organigram agrees to buy Aurora Cannabis at C$7.80 a share, challenging Curaleaf
Organigram Global has signed an arrangement agreement to acquire all outstanding shares of Aurora Cannabis at C$7.80 per share. The deal sets up a contest with Curaleaf, whose enhanced hostile bid from October 6 remains outstanding. Curaleaf says its offer is superior and accuses Aurora's board of refusing to engage or grant it due-diligence access.
Why it matters: A friendly deal against a live hostile offer turns Aurora into the centerpiece of a cannabis consolidation fight, with Curaleaf questioning the details Aurora and Organigram haven't disclosed, including the break fee and investor rights for BAT.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following consumer and retail M&A?
The day's biggest deals, consumer and retail included, in one five-minute email every morning. Built for dealmakers and investors. Free, with no paywalled links.
See what you get →